Try our beta test site
63 studies found for:    NIAID | Open Studies | healthy
Show Display Options
Rank Status Study
21 Recruiting Study of Antibiotic-induced Vaginal Yeast Infections in Healthy Women
Conditions: Microbiome;   Antibiotic-Induced VVC;   Vaginal Candidiasis
Intervention:
22 Not yet recruiting Multiple Ascending Dose Study of Oxfendazole in Healthy Adult Volunteers
Condition: Helminthic Infection
Intervention: Drug: Oxfendazole
23 Recruiting Evaluation of Human Immune Responses to Influenza Virus Vaccination in Healthy Volunteers
Condition: Influenza
Intervention: Biological: Trivalent inactivated influenza vaccine
24 Not yet recruiting MVA-BN®-Filo and Ad26.ZEBOV Vaccines in Healthy Volunteers
Conditions: Ebola Disease;   Marburg Disease
Interventions: Biological: Ad26 Zaire Ebola Vaccine;   Biological: MVA Multi-Filo Ebola Vaccine
25 Recruiting Aerosolized and Intravenous Colistin in Healthy Adults
Conditions: Pneumococcal Infection;   Pneumonia;   Pathogen Resistance
Intervention: Drug: Colistimethate sodium
26 Recruiting Phase 1 Study of dmLT ID Vaccination in Healthy Adults
Condition: Gastroenteritis Escherichia Coli
Interventions: Other: Placebo;   Biological: Recombinant Double Mutant Heat-Labile Toxin LT(R192G/L211A) (dmLT) Oral entertoxigenic Escherichia coli (ETEC) Vaccine
27 Recruiting PfSPZ Challenge in Healthy Malaria-Naïve Adults in the United States
Condition: Plasmodium Falciparum Infection
Interventions: Drug: Chloroquine;   Other: Placebo;   Biological: PfSPZ
28 Recruiting H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults: Immunology
Condition: Avian Influenza
Interventions: Drug: AS03;   Drug: MF59;   Biological: Monovalent Influenza A/H5N8 vaccine
29 Not yet recruiting Evaluating the Safety, Pharmacokinetics, and Anti-Viral Activity of VRC01 and VRC01LS in the Serum and Mucosa of Healthy, HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: VRC01;   Biological: VRC01LS
30 Recruiting Safety and Immunogenicity of the Dengue Virus Vaccine TV005 (TetraVax-DV TV005) in Healthy Adults, Adolescents, and Children in Dhaka, Bangladesh
Condition: Dengue
Interventions: Biological: TV005 vaccine;   Biological: Placebo
31 Recruiting Evaluating the Safety and Immunogenicity of HIV Clade C DNA Vaccine and MF59- or AS01B-Adjuvanted Clade C Env Protein Vaccines in Various Combinations in Healthy, HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: DNA-HIV-PT123 vaccine;   Biological: Bivalent Subtype C gp120/MF59 vaccine;   Biological: Bivalent Subtype C gp120/AS01B vaccine;   Biological: Placebo
32 Recruiting A Phase I Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of MVA-BN Yellow Fever Vaccine With and Without Montanide ISA-720 Adjuvant in 18-45 Year Old Healthy Volunteers
Condition: Yellow Fever
Interventions: Drug: ISA-720;   Biological: MVA Smallpox Vaccine;   Biological: MVA-BN Yellow Fever Vaccine;   Other: Placebo;   Biological: YF Vax 17D Strain
33 Not yet recruiting Evaluating the Immunogenicity of the AIDSVAX B/E Vaccine and the MVA/HIV62B Vaccine in Healthy, HIV-1-Uninfected Adults Who Previously Received MVA/HIV62B in DNA/MVA or MVA/MVA Regimens in HVTN 205
Condition: HIV Infections
Interventions: Biological: MVA/HIV62B vaccine;   Biological: AIDSVAX B/E vaccine;   Biological: Placebo
34 Recruiting A Phase 1, First-in-human, Double-blinded, Randomized, Placebo-controlled Trial of a Zika Virus Purified Inactivated Vaccine (ZPIV) With Alum Adjuvant in Healthy Flavivirus-naive and Flavivirus-Primed Subjects.
Condition: Zika Virus Infection
Interventions: Biological: IXIARO;   Biological: YF Vax 17D Strain;   Biological: Zika Virus Purified Inactivated Vaccine (ZPIV)
35 Recruiting Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis
Conditions: Healthy Participants;   Rheumatoid Arthritis (RA) Prevention
Interventions: Drug: Hydroxychloroquine;   Drug: HCQ Placebo
36 Recruiting Tissue Biopsy and Imaging Studies in HIV-Infected Patients
Conditions: HIV;   Healthy Volunteers
Intervention:
37 Recruiting Evaluation and Follow-up of Patients With Cryptococcosis
Condition: Cryptococcosis
Intervention:
38 Recruiting VNRX-5133 SAD/MAD Safety and PK in Healthy Adult Volunteers
Condition: Bacterial Infections
Interventions: Drug: VNRX-5133;   Drug: Placebo
39 Recruiting A Phase 1, Randomized, Blinded, Dose-escalation Study of rAAV1-PG9DP Recombinant AAV Vector Coding for PG9 Antibody in Healthy Male Adults.
Condition: HIV Infections
Intervention: Biological: rAAV1-PG9DP
40 Recruiting Safety and PK of MBX-400 (Cyclopropavir) in Normal Volunteers
Condition: Cytomegalovirus Infection
Interventions: Other: Placebo;   Drug: MBX400

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.